0001562180-24-003303.txt : 20240404
0001562180-24-003303.hdr.sgml : 20240404
20240404172906
ACCESSION NUMBER: 0001562180-24-003303
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moll Laurent R
CENTRAL INDEX KEY: 0001888601
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40960
FILM NUMBER: 24824113
MAIL ADDRESS:
STREET 1: C/O ARTERIS, INC.
STREET 2: 595 MILLICH DR., SUITE 200
CITY: CAMPBELL
STATE: CA
ZIP: 95008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arteris, Inc.
CENTRAL INDEX KEY: 0001667011
STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674]
ORGANIZATION NAME: 04 Manufacturing
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 E. HAMILTON AVE, SUITE 300
CITY: CAMPBELL
STATE: CA
ZIP: 95008
BUSINESS PHONE: (408) 470-7300
MAIL ADDRESS:
STREET 1: 900 E. HAMILTON AVE, SUITE 300
CITY: CAMPBELL
STATE: CA
ZIP: 95008
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2024-04-02
false
0001667011
Arteris, Inc.
AIP
0001888601
Moll Laurent R
C/O ARTERIS, INC.
900 E. HAMILTON AVE., SUITE 300
CAMPBELL
CA
95008
false
true
false
false
Chief Operating Officer
true
Common Stock
2024-04-02
4
S
false
2206.00
7.0267
D
590872.00
D
Common Stock
2024-04-02
4
S
false
1985.00
7.0267
D
588887.00
D
Common Stock
2024-04-03
4
S
false
581.00
7.1721
D
588306.00
D
Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units.
Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 16, 2023.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.00 to $7.59 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 411,017 restricted stock units.
/s/ Paul Alpern, as Attorney-in-Fact for Laurent R. Moll
2024-04-04